tiprankstipranks
Trending News
More News >
Voyageur Pharmaceuticals (TSE:VM)
:VM
Canadian Market

Voyageur Pharmaceuticals (VM) Income Statement

Compare
20 Followers

Voyageur Pharmaceuticals Income Statement

Last quarter (Q3 2025), Voyageur Pharmaceuticals's total revenue was C$11.04K, an increase of Infinity% from the same quarter last year. In Q3, Voyageur Pharmaceuticals's net income was C$-1.30M. See Voyageur Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -1.57KC$ -2.19KC$ -2.91KC$ -2.25KC$ -1.48K
Operating Expenses
C$ 1.70MC$ 1.22MC$ 1.75MC$ 2.05MC$ 1.00M
Depreciation and Amortization
C$ 1.57KC$ 2.19KC$ 2.91KC$ 2.25KC$ 1.48K
EBITDA
C$ -1.71MC$ -1.22MC$ -1.75MC$ -2.05MC$ -1.12M
Operating Income
C$ -1.70MC$ -1.22MC$ -1.75MC$ -2.05MC$ -848.94K
Other Income/Expenses
C$ -7.94KC$ -178.52KC$ -1.97KC$ -3.28KC$ -154.84K
Pretax Income
C$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05MC$ -1.14M
Net Income
C$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05MC$ -1.14M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.01C$ -0.02C$ -0.02C$ -0.02
Diluted EPS
C$ -0.01C$ -0.01C$ -0.02C$ -0.02C$ -0.02
Weighted Average Shares Outstanding
137.63M 130.51M 107.83M 94.68M 70.53M
Weighted Average Shares Outstanding (Diluted)
137.63M 130.50M 107.83M 94.68M 70.53M
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History